Please use this identifier to cite or link to this item:
https://hdl.handle.net/1889/1942
Title: | Phase II study of Letrozole, metronomic Cyclophosphamide and Sorafenib as neoadjuvant therapy in patients with operable breast cancer: pharmacodynamic and pharmacokinetic analysis. |
Authors: | Bazzola, Letizia |
Publisher: | Università degli Studi di Parma. Dipartimento di Medicina Sperimentale |
Document Type: | Doctoral thesis |
Data: | Mar-2012 |
Rights: | © Letizia Bazzola, 2012 |
Appears in Collections: | Scienze biomediche, biotecnologiche e traslazionali. Tesi di dottorato |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
tesi Bazzola.pdf Until 2101-01-01 | 4.39 MB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.